The layoffs had decimated the workforce that processes Freedom of Information Act requests across FDA centers.

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

At the University of British Columbia, the Blakney Lab is focused on developing vaccines and therapies using self-amplifying ...

Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...

There's new uncertainty about updated COVID-19 shots this fall after the Trump administration's handling of a shot from ...

Right now, it is only approved under emergency use. That’s different from the mRNA vaccines from Pfizer and Moderna, which ...

Bernstein analyst Courtney Breen maintained a Hold rating on Moderna (MRNA – Research Report) yesterday and set a price target of $28.00. The ...

HHS Secretary Robert F. Kennedy Jr. is debating on pulling the Covid-19 vaccine from the government’s list of recommended vaccinations for ...

It is still being sold under emergency use authorization — unlike mRNA vaccines made by Pfizer and Moderna that have earned ...

BioNTech, in collaboration with Pfizer, developed BNT162b2, while Moderna introduced mRNA-1273, each demonstrating over 90% efficacy in clinical trials. These successes catalyzed broader biotech ...